Center-Authored Papers

Browse: Authors | Keywords | All Center-Authored Publications
Filter by Division: Basic | Clinical | Human Biology | PHS | VIDD (2010-present) | VIDI (2008-2009)
Filter by Year: 2008 | 2009 | 2010 | 2011 | 2012 | 2013

Filters: Keyword is Receptor, Epidermal Growth Factor  [Clear All Filters]
C
Chamberlain, MC.  2011.  How fine a slice: treatment of newly diagnosed glioblastoma with an epidermal growth factor receptor variant III peptide vaccine.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(17):e517-8;authorreplye519-20.
Chazin, VR, Kaleko M, Miller AD, Slamon DJ.  1992.  Transformation mediated by the human HER-2 gene independent of the epidermal growth factor receptor.. Oncogene. 7(9):1859-66. Abstract
D
Deng, Y, Kurland BF, Wang J, Bi J, Li W, Rao S, Lan P, Lin T, Lin E.  2009.  High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.. American journal of clinical oncology. 32(3):245-52. Abstract
H
Herbst, RS, Kelly K, Chansky K, Mack PC, Franklin WA, Hirsch FR, Atkins JN, Dakhil SR, Albain KS, Kim ES et al..  2010.  Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(31):4747-54. Abstract
Hesketh, PJ, Chansky K, Wozniak AJ, Hirsch FR, Spreafico A, Moon J, Mack PC, Marchello BT, Franklin WA, Crowley J et al..  2008.  Southwest Oncology Group phase II trial (S0341) of erlotinib (OSI-774) in patients with advanced non-small cell lung cancer and a performance status of 2.. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 3(9):1026-31. Abstract
Hirsch, FR, Kabbinavar F, Eisen T, Martins RG, Schnell FM, Dziadziuszko R, Richardson K, Richardson F, Wacker B, Sternberg DW et al..  2011.  A Randomized, Phase II, Biomarker-Selected Study Comparing Erlotinib to Erlotinib Intercalated With Chemotherapy in First-Line Therapy for Advanced Non-Small-Cell Lung Cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(26):3567-3573. Abstract
J
Jiang, H, Edgar BA.  2009.  EGFR signaling regulates the proliferation of Drosophila adult midgut progenitors.. Development (Cambridge, England). 136(3):483-93. Abstract
Jiang, H, Grenley MO, Bravo M-J, Blumhagen RZ, Edgar BA.  2011.  EGFR/Ras/MAPK signaling mediates adult midgut epithelial homeostasis and regeneration in Drosophila.. Cell stem cell. 8(1):84-95. Abstract
O
O'Keefe, DD, Gonzalez-Niño E, Burnett M, Dylla L, Lambeth SM, Licon E, Amesoli C, Edgar BA, Curtiss J.  2009.  Rap1 maintains adhesion between cells to affect Egfr signaling and planar cell polarity in Drosophila.. Developmental biology. 333(1):143-60. Abstract
P
Pitteri, SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C-H, Zhang Q, Wang H et al..  2010.  Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users.. Cancer research. 70(21):8598-606. Abstract
S
Sequist, LV, Besse B, Lynch TJ, Miller VA, Wong KK, Gitlitz B, Eaton KD, Zacharchuk C, Freyman A, Powell C et al..  2010.  Neratinib, an irreversible pan-ErbB receptor tyrosine kinase inhibitor: results of a phase II trial in patients with advanced non-small-cell lung cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(18):3076-83. Abstract
Shankaran, V, Obel J, Benson AB.  2010.  Predicting response to EGFR inhibitors in metastatic colorectal cancer: current practice and future directions.. The oncologist. 15(2):157-67. Abstract
T
Taguchi, A, Politi K, Pitteri SJ, Lockwood WW, Faça VM, Kelly-Spratt K, Wong C-H, Zhang Q, Chin A, Park K-S et al..  2011.  Lung cancer signatures in plasma based on proteome profiling of mouse tumor models.. Cancer cell. 20(3):289-99. Abstract